| Second-generation drug-eluting coronary stents. | |
| | |
MedLine Citation:
|
PMID: 20445185 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Richard A Lange; L David Hillis |
Related Documents
:
|
18713645 - Thrombus causes fluctuations in arterial drug delivery from intravascular stents. 15665795 - Drug-eluting stents: clinical perspectives on drug and design differences. 19956555 - Luminal flow amplifies stent-based drug deposition in arterial bifurcations. 21091895 - Controversy of proton pump inhibitor and clopidogrel interaction: a review. 9833965 - Round window administration of gentamicin: a new method for the study of ototoxicity of... 10839055 - Perceptual reactance, drug preference, and electrodermal activity in treatment-seeking ... |
Publication Detail:
|
Type: Comment; Editorial |
Journal Detail:
|
Title: The New England journal of medicine Volume: 362 ISSN: 1533-4406 ISO Abbreviation: N. Engl. J. Med. Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-06 Completed Date: 2010-05-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0255562 Medline TA: N Engl J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 1728-30 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary Coronary Artery Disease / therapy* Cost-Benefit Analysis Diabetes Complications / therapy Drug-Eluting Stents* Humans Paclitaxel / administration & dosage* Prosthesis Design Sirolimus / administration & dosage, analogs & derivatives* Thrombosis Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
159351-69-6/everolimus; 33069-62-4/Paclitaxel; 53123-88-9/Sirolimus |
| Comments/Corrections | |
Comment On:
|
N Engl J Med. 2010 May 6;362(18):1663-74
[PMID:
20445180
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of bar-code technology on the safety of medication administration.
Next Document: Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.